Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-03

FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BINOSTO (alendronate sodium) submitted by Radius Health, Inc. The approval concerns an update to the product labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BINOSTO (ALENDRONATE SODIUM)

Snippet

SUPPL AP for BINOSTO (ALENDRONATE SODIUM)